GlassScriptPhysician profile
Zachary Griggs
NPI 1063805992
$3,533.64
in general payments reported to CMS, 2019-2025
23 companies · $975 in 2025
The $975 reported for 2025 was more than what 79% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $76.18 · 2021: $706 · 2022: $192 · 2023: $878 · 2024: $707 · 2025: $975.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,922 · Travel and Lodging: $604 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,921.61 |
| Travel and Lodging | $603.94 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $958.98 | 2023-2025 | Inspire |
| Intersect Ent, INC. | $601.10 | 2021-2022 | |
| Glaxosmithkline, LLC. | $594.19 | 2022-2025 | Nucala |
| Integra Lifesciences Corporation | $359.02 | 2024-2025 | Acclarent Aera, Relieva Spinplus Nav, Trudi Probe |
| Acclarent, INC | $268.51 | 2020-2023 | Trudi Nav Cable, Acclarent Aera |
| Neurent Medical Limited | $143.69 | 2022-2023 | Neuromark Radiofrequency Console, Neuromark Device |
| Genzyme Corporation | $125.15 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $80.01 | 2023-2025 | Dupixent |
| Smith+Nephew, INC. | $79.56 | 2020-2023 | Grafix Pl |
| Merck Sharp & Dohme LLC | $59.36 | 2021-2025 | Keytruda |
| Ethicon US, LLC | $36.98 | 2025 | Harmonic |
| Amgen INC. | $34.00 | 2025 | |
| Novartis Pharmaceuticals Corporation | $29.79 | 2024 | |
| Dutch Ophthalmic, USA | $29.63 | 2024 | Tissueblue, Eva, Combined Machine |
| Ambu INC. | $18.63 | 2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $18.18 | 2024 | Erleada |
| Emd Serono, INC. | $16.19 | 2022 | |
| Kaleo, INC. | $15.21 | 2022 | |
| Puma Biotechnology, INC. | $14.56 | 2020 | |
| Harrow Eye, LLC | $13.94 | 2024 | Iheezo |
| Eisai INC. | $13.70 | 2021 | |
| Incyte Corporation | $11.65 | 2021 | |
| Cochlear Americas | $11.61 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zachary Griggs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.